Plazy Mélanie, Dray-Spira Rosemary, Orne-Gliemann Joanna, Dabis François, Newell Marie-Louise
Centre de recherche Inserm U897 Epidémiologie et Biostatistique, Université Bordeaux, Bordeaux, France.
Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université Bordeaux, Bordeaux, France.
Trop Med Int Health. 2014 Jun;19(6):680-689. doi: 10.1111/tmi.12301. Epub 2014 Mar 21.
OBJECTIVE: To quantify time from entry in HIV care until Antiretroviral therapy (ART) initiation and identify factors associated with ART initiation in rural KwaZulu-Natal, South Africa. METHODS: Adults ≥16 years entering the decentralised Hlabisa ART programme between 2007 and 2011 were followed until June 2013. Median survival times to ART initiation from date of programme entry and from date of ART eligibility were estimated with Kaplan-Meier methods. Associated factors were evaluated in Cox regressions, censoring for deaths. RESULTS: Of 37 749 adults (71.6% female), 17 638 (46.7%) initiated ART. Nearly half (46.9%) met the CD4 criteria for treatment eligibility at programme entry. Among the 20 039 individuals not yet ART-eligible at entry, only 62.5% were retained in care with at least one further CD4 measurement, of whom 6688 subsequently became ART-eligible. Overall, 65.5% of the 24 398 ART-eligible individuals initiated ART over the study period. ART initiation was more likely in women (P < 0.001), in individuals ≥ 25 years old (P < 0.001) and in patients with low CD4 count (P < 0.001). Patients who became eligible during follow up were significantly more likely to initiate ART than those eligible at programme entry (72.6% vs. 62.9%, Adjusted Hazard Ratio = 1.46; 95% Confidence Interval [1.41-1.51]), adjusting for sex, age, year and CD4 count at eligibility. CONCLUSIONS: In this rural programme, continuation of care remains challenging, especially in men and younger adults. ART initiation is more likely in those engaged prior eligibility than in those entering HIV care only late in their HIV disease.
目的:量化南非夸祖鲁 - 纳塔尔省农村地区从进入艾滋病护理到开始抗逆转录病毒治疗(ART)的时间,并确定与开始ART相关的因素。 方法:对2007年至2011年间进入分散式赫拉比萨ART项目的16岁及以上成年人进行随访,直至2013年6月。采用Kaplan - Meier方法估计从项目进入日期和符合ART治疗标准日期到开始ART的中位生存时间。在Cox回归中评估相关因素,并对死亡进行截尾处理。 结果:在37749名成年人(71.6%为女性)中,17638人(46.7%)开始接受ART治疗。近一半(46.9%)在项目进入时符合治疗资格的CD4标准。在进入时尚未符合ART治疗资格的20039人中,只有62.5%的人在接受护理期间至少进行了一次CD4检测,其中6688人随后符合了ART治疗资格。总体而言,在研究期间,24398名符合ART治疗资格的人中,65.5%开始接受ART治疗。女性(P < 0.001)、25岁及以上的个体(P < 0.001)和CD4计数低的患者(P < 0.001)更有可能开始接受ART治疗。在随访期间符合资格的患者比在项目进入时符合资格的患者更有可能开始接受ART治疗(72.6%对62.9%,调整后的风险比 = 1.46;95%置信区间[1.41 - 1.51]),对性别、年龄、年份和符合资格时的CD4计数进行了调整。 结论:在这个农村项目中,持续护理仍然具有挑战性,尤其是在男性和年轻人中。在符合资格之前就参与护理的人比在艾滋病病程后期才进入艾滋病护理的人更有可能开始接受ART治疗。
Trop Med Int Health. 2014-6
Trop Med Int Health. 2018-7-26
Trop Med Int Health. 2014-12
BMC Public Health. 2021-3-20